The ALIGN Consortium convened partners with a clear purpose: to strengthen country-led decision-making systems that determine how health product innovations are prioritized and introduced. At its core, ALIGN is about ensuring that innovation is not left to chance, but guided by structured, transparent, and evidence-based processes that improve health outcomes sustainably.
The meeting began by situating ALIGN within the global context of innovation introduction, reflecting on how shifting health financing landscapes, regulatory environments, and emerging technologies require more deliberate and coordinated national approaches. The team had a recap from the previous meeting, drawing lessons from initial discussions and identifying opportunities to refine the approach.
Key project milestones were presented, offering a clear sense of progress and reinforcing the Consortium’s commitment to measurable impact. Deliberations then moved into planned activities across the four pillars of ALIGN: strengthening whole-of-government coordination and capacity, advancing data-driven decision-making, deepening whole-of-market engagement, and enhancing advocacy. These conversations emphasized that effective innovation introduction requires alignment across policy, financing, regulatory systems, market actors, and community perspectives.
By strengthening these pillars, ALIGN is helping build more efficient and equitable pathways from innovation to impact.
#Align #Heathinnovation #innovationintroduction